<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib59">
 <label>59</label>
 <element-citation publication-type="journal" id="sref59">
  <person-group person-group-type="author">
   <name>
    <surname>Thanigaimalai</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Konno</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Koiwai</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Taguchi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Takayama</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yakushiji</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Akaji</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Naser-Tavakolian</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sch√∂n</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Freire</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hayashi</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies</article-title>
  <source>Eur. J. Med. Chem.</source>
  <volume>68</volume>
  <year>2013</year>
  <fpage>372</fpage>
  <lpage>384</lpage>
  <pub-id pub-id-type="pmid">23994330</pub-id>
 </element-citation>
</ref>
